Genzyme Providing Renagel At Discount To Seniors Ahead Of Medicare Rx
Executive Summary
Genzyme's REACH program will provide the renal disease therapy Renagel to Medicare beneficiaries ahead of the senior prescription drug benefit in 2006
You may also be interested in...
Genzyme Renagel Growth To Come From Medicare Rx, Kidney Disease Use
Genzyme expects results from a Phase IV Renagel outcomes study to bolster the phosphate binder's long-term growth prospects, Renal Division General Manager John Butler told investors Feb. 19
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials